DOI: 10.4244/EIJV9I4A86

Late aortic perforation with a fractured ATRIASEPT II device resulting in life-threatening tamponade

Francisco José Hernández Pérez1*, MD; José Antonio Fernández Díaz1, MD; Carlos García Montero2, MD, PhD; Arturo García Touchard1, MD; Juan Francisco Oteo Domínguez1, MD; José Ramón Domínguez Puente1, MD; Javier Goicolea Ruigómez1, MD

A 32-year-old female suffered a transient ischaemic attack (TIA) in the territory of the middle cerebral artery, and a patent foramen ovale (PFO) and an atrial septal aneurysm (ASA) were diagnosed using transoesophagic echocardiography (TEE). A 20 mm ATRIASEPT™ (Cardia Inc., Eagan, MN, USA) device was successfully implanted.

Three months later the patient was admitted to hospital in shock with cardiac tamponade. Pericardiocentesis was immediately performed but haemodynamic instability meant transferring the patient to the operating room (OR) for emergency surgery.

Intraoperatively, lacerations in the aorta and the top of the right atria were identified (Figure 1). Defects were provisionally repaired and the patient was stabilised in the intensive care unit. Echocardiography and fluoroscopy showed a correct position and no structural damage of the device. Days later, on-pump surgery was performed and the device was removed. The ATRIASEPT device showed the following defect in the structure: several of the coupler wires attached to one of the right/centre struts were fractured (Figure 2). This defect had eroded the right atrium and aortic root causing the damage.

Figure 1. Intraoperative image. The arrow points to the wires that caused the lacerations in the aorta and the top of the right atria.

Figure 2. Details of the device removed. Several of the coupler wires attached to one of the right/centre struts were fractured.

The patient recovered well in the postoperative period and was discharged 25 days later, uneventfully. In the follow-up performed 12 months later the patient was well without sequelae.

Conflict of interest statement

The authors have no conflicts of interest to declare.

Volume 9 Number 4
Aug 23, 2013
Volume 9 Number 4
View full issue


Key metrics

Suggested by Cory

Research correspondence

10.4244/EIJ-D-21-01021 May 15, 2022
Mechanisms of ineffective patent foramen ovale closure using the percutaneous suture-mediated NobleStitch system
Zannoni J et al
free

State-of-the-Art

10.4244/EIJ-D-23-01084 Aug 19, 2024
Antithrombotic therapy for transcatheter structural heart intervention
Guedeney P et al
free

CLINICAL RESEARCH

10.4244/EIJ-D-15-00499 Apr 20, 2017
AMPLATZER versus Figulla occluder for transcatheter patent foramen ovale closure
Trabattoni D et al
free

IMAGE IN CARDIOLOGY

10.4244/EIJY15M03_07 Oct 20, 2015
Interventional retrieval by catheter of a migrated atrial appendage occluder located in the arcus aortae
Bogunovic N et al
free
Trending articles
152.9

Clinical research

10.4244/EIJ-D-20-01125 Oct 20, 2021
An upfront combined strategy for endovascular haemostasis in transfemoral transcatheter aortic valve implantation
Costa G et al
free
47.8

NEW INNOVATION

10.4244/EIJ-D-15-00467 Feb 20, 2018
Design and principle of operation of the HeartMate PHP (percutaneous heart pump)
Van Mieghem NM et al
free
39.1

Clinical research

10.4244/EIJ-D-22-00558 Feb 6, 2023
Permanent pacemaker implantation and left bundle branch block with self-expanding valves – a SCOPE 2 subanalysis
Pellegrini C et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved